• Contact quintiles

    Phone:+1 866 267 4479

    Request a Proposal

  • Therapeutic Expertise Public Health Interest

  • clinical-trials-header
  • Quintiles Clinical Trial

    Navigating global public health challenges requires a partner at the intersection of therapeutic expertise and government policy. 

    By securing Product Development Partnerships (PDPs) and contracts or grants with governments, non-profit organizations and biopharma, Quintiles supports efficient development of products that improve public health and enhance readiness for emerging or neglected diseases and bioterrorism.

    Clinical development expertise for public health solutions

    Working with government and other subsidized programs, Quintiles specializes in clinical development of products and devices that address public health issues including:

    • Global health threats such as HIV/AIDS, influenza, malaria and tuberculosis 
    • Less well-recognized health threats to the developing world such as hookworm and leishmaniasis
    • Biological, chemical and radiological threats (i.e., anthrax, botulism and others) 
    • Lifestyle diseases and conditions that impact global public health such as obesity, respiratory conditions, cardiovascular diseases and cancer 

    In addition to helping you secure government and other non-dilutive funding for public health clinical research projects, we will ensure your program or project is planned, executed and delivered in full compliance with applicable government regulations and requirements (e.g., Federal Acquisition Regulation – FAR).

    Quintiles serves as a preferred provider to a consortium of 14 global health PDPs and was also the first CRO to endorse the United Against Neglected Tropical Diseases Initiative led by WHO and The Gates Foundation.  

  • Global public health expertise

  • Quintiles Clinical Trails

    Quintiles announced that it has been named a preferred provider to a consortium of 14 global health Product Development Partnerships (PDPs).
    Read press release

  • Quintiles Clinical Trails

    After decades of work mapping the human genome, we are beginning to reap real benefits through the tools of pharmacobiomics.
    Read white paper